clinical-stage biotechnology company
Onechain Immunotherapeutics has raised €6.7M across 1 funding round from 5 investors, most recently a Seed round in Jun 2023. Based in Barcelona, Spain; active in Healthtech. Data as of 6 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-06-22 | Seed | €6.7M |
| CDTI,Clave Capital,Invivo Capital Partners,Josep Carreras Foundation,Nara Capital |
| View deal → |
